Patents

, (Baker & McKenzie FenXun (FTZ))/

In Linklinear Development Co., Ltd. v. Shanghai Baoye Group Corp., Ltd., [(2019) SPC. IP. Civil. Jur. Fin. No. 2] (November 1, 2019), the IP Tribunal of the Supreme People’s Court (“SPC”) affirmed a lower court’s decision denying the transfer of Linklinear’s later-filed infringement action to another court that hears a first-filed declaratory judgment action, holding…

Case Law, China, Infringement, SPC

, , (Baker & McKenzie FenXun (FTZ))/

The IP Tribunal of the Supreme People’s Court (SPC) recently issued a decision in Dunjun v. Tengda ((2019) SPC IP Civil No. 147), holding that the manufacturer’s making and selling of routers directly infringed a telecommunication method-of-use patent even though the manufacturer itself did not perform one single step of the patented method. This article…

China, Infringement, Litigation, Patents, SPC

, (Baker & McKenzie FenXun (FTZ))/

On 5 December 2019, the IP Tribunal of the Supreme People’s Court (SPC) handed down two decisions in which – in a first for China, the SPC heard and decided on both the patent validity and infringement disputes in one consolidated proceeding.  Background The two actions arose out of a patent infringement dispute between the…

Case Law, China, Infringement

, (Baker & McKenzie) and (Baker & McKenzie FenXun (FTZ))/

Declaratory-judgment actions of non-infringement are common in patent litigation because it allows the alleged infringer to proactively bring suit to resolve the situation and eliminate the cloud of uncertainty looming overhead. Under Chinese law, to bring a claim for declaratory judgment in a patent dispute, the claimant must establish that: (1) the patentee sends a…

(Cross-border) jurisdiction, China, Legislation

(Baker & McKenzie), (Baker & McKenzie FenXun (FTZ)), and (ZY Partners)/

In our blog of last December, we reported that China has established a new IP Tribunal within the Supreme People’s Court (the “SPC”) as a national IP appellate court akin to the federal circuit in the United States. The new SPC IP Tribunal commenced operation from Jan 1, 2019 in Beijing. Interim Judgment On March…

Case Law, China, Disclaimer, Infringement, Procedure, Scope of protection

(Baker & McKenzie), (Baker & McKenzie FenXun (FTZ)), and (ZY Partners)/

In China, a patent owner’s statements made during prosecution or invalidation may give rise to prosecution history estoppel (or prosecution disclaimer), which precludes the patent owner from recapturing subject matter that was relinquished during prosecution or invalidation in subsequent infringement actions. To invoke the doctrine of prosecution disclaimer, such statements must constitute a clear and…

Biologics, China, Litigation, Pharmaceutical patent

(Baker & McKenzie), (Baker & McKenzie FenXun (FTZ)), and , (ZY Partners)/

On October 8, 2017, the Chinese Communist Party and the State Council jointly issued a special opinion on the reform of drug and medical device approval system (“Innovation Opinion”). The Innovation Opinion together with an earlier China Food and Drug Administration (“CFDA”) document (“Circular No. 55”) issued in May 2017 (collectively “Reform Opinion”), propose that…

Case Law, China, Enforcement, Prior art, Validity

(Baker & McKenzie FenXun (FTZ)), (ZY Partners), and (Baker & McKenzie)/

The recent Apple v. Baili case has generated a wide interest in design patents. This article discusses developments on judicial standards for determining design patent infringement applied in Apple v. Baili, and some implications from this case. Such standards involve how to determine distinctive features, what to be considered to differentiate a functional feature, what…

(Compulsory) license, (Indirect) infringement, China, SEP

(Baker & McKenzie), (Baker & McKenzie FenXun (FTZ)), and (ZY Partners)/

On March 22, 2017, the Beijing IP Court (the “trial court”) issued a decision on a high-profile case Iwncomm v. Sony concerning infringement of a standard essential patent (SEP). This case has drawn extensive attention in China’s IP community because it is the first SEP-based injunction granted by a Chinese court, and it involves quite…